Bothde novosynthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bothde novosynthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 37, Issue 1, Pages 80-89
Publisher
Wiley
Online
2016-06-06
DOI
10.1111/liv.13183
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- (2016) Fabio Piscaglia et al. HEPATOLOGY
- Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
- (2016) Lei Li et al. JOURNAL OF HEPATOLOGY
- LPLgene expression is associated with poor prognosis in CLL and closely related toNOTCH1mutations
- (2015) Louise Kristensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
- (2015) U. Rozovski et al. MOLECULAR CANCER RESEARCH
- Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer
- (2015) Junyan Tao et al. Oncotarget
- Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
- (2014) Xin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches
- (2014) E Callegari et al. CELL DEATH AND DIFFERENTIATION
- A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver
- (2014) Aras N. Mattis et al. HEPATOLOGY
- Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
- (2014) Hashem B. El-Serag et al. HEPATOLOGY
- Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
- (2012) Donna L. White et al. Clinical Gastroenterology and Hepatology
- Annual Incidence of Hepatocellular Carcinoma Among Patients With Alcoholic Cirrhosis and Identification of Risk Groups
- (2012) Alejo Mancebo et al. Clinical Gastroenterology and Hepatology
- Lipid metabolism in cancer
- (2012) Claudio R. Santos et al. FEBS Journal
- Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells
- (2012) Edward Kai-Hua Chow et al. HEPATOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2,
- (2011) Coral Ho et al. HEPATOLOGY
- Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation
- (2011) N. B. Kuemmerle et al. MOLECULAR CANCER THERAPEUTICS
- Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
- (2010) Z. M. YOUNOSSI ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity
- (2010) Darko Cerne et al. ARCHIVES OF MEDICAL RESEARCH
- Fatty acid synthase as a potential therapeutic target in cancer
- (2010) Richard Flavin et al. Future Oncology
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
- (2009) R. C. Kane et al. ONCOLOGIST
- Novel advancements in the management of hepatocellular carcinoma in 2008
- (2008) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started